Merck's Zerbaxa Approved by China's NMPA for Complex Infections
CompanyDrug

Merck’s Zerbaxa Approved by China’s NMPA for Complex Infections

Hainan Unveils Biomedical New Technology Policy to Boost Medical Innovation
Policy / Regulatory

Hainan Unveils Biomedical New Technology Policy to Boost Medical Innovation

Roche's Evrysdi Tablet Approved by FDA for Spinal Muscular Atrophy
CompanyDrug

Roche’s Evrysdi Tablet Approved by FDA for Spinal Muscular Atrophy

Shanghai's Ambitious Plan to Revolutionize Brain-Computer Interfaces
Policy / Regulatory

Shanghai’s Ambitious Plan to Revolutionize Brain-Computer Interfaces

Pfizer's Adcetris Gets New FDA Approval for Lymphoma Treatment
CompanyDrug

Pfizer’s Adcetris Gets New FDA Approval for Lymphoma Treatment

StairMed Raises Record RMB350m for Implantable BCI Development
CompanyDeals

StairMed Raises Record RMB350m for Implantable BCI Development

Lundbeck's Amlenetug Receives FDA Fast Track for Multiple System Atrophy
CompanyDrug

Lundbeck’s Amlenetug Receives FDA Fast Track for Multiple System Atrophy

OnCusp Therapeutics' CUSP06 Receives FDA Fast Track for Ovarian Cancer
CompanyDrug

OnCusp Therapeutics’ CUSP06 Receives FDA Fast Track for Ovarian Cancer

J&J Considers Selling Stroke Care Business Cerenovus for USD1-1.5 Billion
CompanyDeals

J&J Considers Selling Stroke Care Business Cerenovus for USD1-1.5 Billion

Anhui Anke to Invest in Visen Pharma's Hong Kong IPO as Cornerstone Investor
CompanyDeals

Anhui Anke to Invest in Visen Pharma’s Hong Kong IPO as Cornerstone Investor

Boao Airport Customs Releases First Batch of Modulen IBD for Crohn's Disease Management
CompanyDrug

Boao Airport Customs Releases First Batch of Modulen IBD for Crohn’s Disease Management

AbbVie Collaborates with Xilio Therapeutics on Tumor-Activated Immunotherapies
CompanyDeals

AbbVie Collaborates with Xilio Therapeutics on Tumor-Activated Immunotherapies